Alaya Capital

Alaya Capital is a regional venture firm with strong presence in Argentina and Chile, backing software-as-a-service startups across LatAm. Check sizes of $250k to $1M place the firm in the seed range. Healthcare exposure is read through digital health and health-IT software. The firm is not specifically AI-focused; the lens is B2B SaaS commercial fundamentals.

The firm’s natural fit is with LatAm founders building B2B SaaS with defined enterprise customers, including healthcare-specific applications such as practice management software, RCM, telehealth back-office, clinical workflow, and health benefits platforms. The right founder profile is a technical or operationally savvy team building software with credible enterprise traction and a clear LatAm-to-US expansion thesis. Founders building DTC consumer health, biotech, or pure US-market software without LatAm wedge are not the natural target.

Geographically, Alaya’s advantage is the Argentina-Chile dual footprint, which is among the strongest combinations for LatAm B2B SaaS given the technical talent in both markets and the regulatory clarity of Chile combined with the engineering depth of Argentina. For founders looking to build a regional SaaS company with operational anchors in either country, Alaya is a credible early partner. For founders without regional ties, the strategic logic is thinner.

The right entry path is a warm intro from a portfolio founder or another regional VC. The firm reads partner-led decks and responds to clear B2B SaaS pitches with credible early revenue evidence. The pitch should lead with ARR, growth rate, gross margin, retention metrics, and the specific LatAm enterprise wedge. Healthcare-specific pitches should explain how the product navigates regional payer dynamics and regulatory considerations.

Caveats. Argentine fund operations are subject to local FX and capital control dynamics that can complicate cross-border rounds; structure cross-border holdings deliberately. The firm’s healthcare-specific portfolio depth is not as visible publicly as its broader SaaS portfolio; reference calls with portfolio founders are advisable. The check size is moderate; for founders raising larger seeds, Alaya should be a participant alongside a real lead. For LatAm B2B SaaS founders building healthcare-adjacent software with regional anchors, Alaya is a credible early partner; for founders without regional ties, the fit is weaker.